Full Guide to Chongqing Nidule Import Agency Procedures: Key Points of Customs Valuation and Commodity Pre-inspection
Importing from China?
Need help with sourcing, customs or shipping?
Your China Import Partner
Reliable sourcing and import agency services.
Core Procedures and Regulatory Framework for Chongqing Nidule Import Agency
To carry out Nidule import agency business in Chongqing,it is necessary to strictly follow the principle of "access license first,whole-process compliance verification".Regulation on pharmaceutical import has been tightened in 2026.Taking Nidule (assumed to be an imported pharmaceutical) as an example,4 core links shall be covered with priority: customs valuation,commodity pre-inspection,processing of Drug Registration Certificate,and port inspection response.With the coordination capability between its Shanghai headquarters and national ports,Zhongshitong can assist Chongqing enterprises in completing off-site declaration,document pre-inspection and local inspection coordination.

I.Customs Valuation: Price Verification Logic for Pharmaceutical Products
Chongqing Customs focuses on two-dimensional verification of "authentic transaction background + market comparable price" for the valuation of imported pharmaceuticals.Zhongshitong recommends preparing the following in advance:
- Duty-paid price certificate of the pharmaceutical’s country of origin (such as detailed composition of CIF price,including transportation,insurance and other related expenses);
- Filing form of declared prices of similar pharmaceuticals at domestic ports in the past 6 months (available via the AEO system of the General Administration of Customs);
- Confirmation letter of customs classification code corresponding to the pharmaceutical’s ingredients and dosage forms (HS code shall be accurate to 10 digits,such as "3004909090").
Practical Case: A Chongqing pharmaceutical enterprise imported Nidule tablets in January 2026,and was subject to customs targeted inspection due to incorrectly filling the HS code as "30049090" (without detailed dosage form classification).Through three-dimensional comparison of "ingredient - dosage form - specification" and supplementing the Pharmaceutical Reference Standard Inspection Report,Zhongshitong completed classification correction within 3 working days,avoiding demurrage losses.
II.Commodity Pre-inspection: Key Nodes of Label Compliance and Entry Inspection and Quarantine
Chongqing commodity inspection authority implements the "three-review system" for imported pharmaceutical labels: content review of Chinese labels,verification of labels on minimum sales units,and inspection of label pasting standardization.The following shall be completed in advance:
| Label Element | Special Requirements of Chongqing Commodity Inspection (New Regulations 2026) | Suggested Responses |
|---|---|---|
| Generic Name | Font height ≥12mm,located in the center of the label | Use laser marking machine to ensure clarity |
| Indications/Functions and Indications | Shall be prefixed with "Imported Drug Registration Certificate Number" | Submit label samples to NMPA for filing 30 days in advance |
| Storage Conditions | Shall be marked with both "temperature range + humidity range" | Present in two columns of Chinese and English for comparison to avoid ambiguity |

Risk Point: In 2026,Chongqing added mandatory requirements for "pharmaceutical cold chain transportation labels",including transportation temperature curve and time stamp.It is recommended that agency enterprises verify logistics documents simultaneously.
III.Processing of Pharmaceutical Import License: Approval Process and Time Limit Prediction
As an imported pharmaceutical,Nidule requires completion of processing of both the Drug Import Clearance Form and the Imported Drug Registration Certificate before entry.Zhongshitong’s experience shows that:
- Chongqing NMPA adopts the mode of "local preliminary review + Shanghai NMPA final review" for first-time imported pharmaceuticals,with the processing period extended to 45 working days;
- The Pharmaceutical Ingredient Analysis Report (including heavy metal residue and microbial indicators) shall be submitted in advance,and the "genotoxic impurity" test item was added in 2026;
- If the pharmaceutical contains special ingredients such as ephedrine,an additional Stimulant Test Report shall be submitted.
Pitfall Avoidance Guide: Never wait until the goods arrive at the port to supplement required certificates!Zhongshitong recommends starting the application 90 days in advance,and coordinating the approval progress through the "Shanghai Headquarters - Chongqing NMPA" green channel.
IV.Port Inspection Response: Coordination Between Chongqing Local Inspection and Off-site Declaration
In 2026,Chongqing Port implements "7×24 hour priority inspection" for high-risk pharmaceuticals.Zhongshitong’s agency advantages are reflected in:
- "Off-site declaration" across national ports: With AEO enterprise qualification in Shanghai,realize "one declaration,direct port release" at Chongqing Port;
- Pre-inspection rehearsal: Provide the Simulated Inspection Checklist (including 12 mandatory inspection items),such as tightness of pharmaceutical packaging and integrity of user instructions;
- Fast release after inspection: The average duration of local inspection in Chongqing is 2.3 hours,and Zhongshitong can coordinate the linkage of "inspector + document examiner" to speed up the process.
2026 Early Warning on Risks of Chongqing Nidule Import Agency
Three types of risks shall be paid special attention to: First,delay in processing of Drug Registration Certificate ("clinical data traceability verification" was added in 2026); Second,price disputes in the valuation link (it is recommended to lock quotations from 3 suppliers in advance); Third,exchange loss risk (reduce fluctuations through "cross-border RMB settlement + exchange rate locking").Zhongshitong’s risk control system has covered:
- Establish a "red-yellow-blue" three-level risk early warning mechanism.In case of customs query,the Price Rationality Analysis Report will be issued within 2 hours;
- Set up an "inspection emergency team" with more than 2 customs brokers in Chongqing to ensure that goods detention time does not exceed 48 hours;
- Provide "7×12 hour" emergency response service,and added the value-added service of "pharmaceutical import insurance" in 2026,covering losses caused by inspection delays.
Conclusion: Professional Selection Criteria for Chongqing Nidule Import Agency
Enterprises shall give priority to checking whether the agency has: ① National network covering Shanghai headquarters and Chongqing branch; ② AEO certification qualification for pharmaceutical products; ③ Successful cases of similar pharmaceutical agency in the past 3 years (for example,for the Nidule import project of a Chongqing pharmaceutical enterprise,the customs clearance time was reduced from 7 days to 3 days).With 20 years of industry experience,Zhongshitong has built a full-chain closed loop of "pre-inspection - classification - inspection - release",helping Chongqing enterprises import high-quality pharmaceuticals from all over the world safely and compliantly.
Recent Comments (0) 0
Leave a Reply